Landscapes / Companies

Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved
Next date
Belzutifan, Phase 2 trial completes
Drugs
2
in active trials
Trials
4 active
5 since 2021

Drugs2

DrugHow it worksPartnerStageNext dateDetails
Hypoxia-inducible factor inhibitor
Merck & Co.
Approved 26 Feb 2027Phase 2 trial completes
—
Phase 1 —

About

SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Following is part of Solo: you see every change to Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in